An anticonvulsant is a medication designed to reduce or prevent seizures by calming excessive electrical activity in the brain. While seizure control is their primary purpose, anticonvulsants are now widely prescribed for conditions that have nothing to do with epilepsy, including bipolar disorder, nerve pain, and certain types of chronic headache. More than 25 anticonvulsant drugs are currently available, spanning three generations of development.
How Anticonvulsants Work in the Brain
Seizures happen when groups of nerve cells fire too rapidly and in sync. Anticonvulsants interrupt this process through several different strategies, and not all of them work the same way.
The most common approach involves ion channels, the tiny gates on nerve cells that control electrical signaling. Some anticonvulsants block sodium channels, making it harder for a nerve cell to fire repeatedly. Others target calcium channels, which reduces the release of chemical messengers between neurons. A third group enhances the brain’s main calming signal, a neurotransmitter called GABA. When GABA binds to its receptor, it opens chloride channels that quiet nerve cell activity. Drugs like benzodiazepines and barbiturates amplify this process by making the GABA receptor complex more efficient. Still other anticonvulsants work by reducing glutamate, the brain’s primary excitatory signal, so there’s less “go” competing with the “stop.”
Many anticonvulsants use more than one of these strategies simultaneously, which is part of why a single drug can treat several different conditions.
Three Generations of Drugs
Anticonvulsants are grouped into generations based on when they were developed, not by their chemical structure or how they work.
First-generation drugs date from 1912 through the 1970s and include phenobarbital, phenytoin, carbamazepine, valproic acid, ethosuximide, and primidone. These medications are effective but come with well-known drawbacks: phenytoin has unpredictable dosing behavior at higher levels, carbamazepine can speed up its own breakdown in the body over time, and several of these older drugs bind heavily to blood proteins, making interactions with other medications common.
Second-generation drugs arrived starting in 1993 with felbamate, followed by gabapentin, lamotrigine, levetiracetam, oxcarbazepine, tiagabine, topiramate, pregabalin, and zonisamide. These were designed with better pharmacological profiles in mind: more predictable absorption, less protein binding, and less reliance on liver enzymes for processing. The result is generally fewer drug interactions and more straightforward dosing.
Third-generation drugs begin with lacosamide, approved in 2008, and include eslicarbazepine, rufinamide, brivaracetam, perampanel, vigabatrin, clobazam, and ezogabine. The most recently approved anticonvulsant is ganaxolone. As a group, third-generation drugs share good absorption and relatively low protein binding, though a few exceptions still interact with liver enzymes. Overall, they tend to cause fewer interactions with other medications than older options.
Epilepsy and Seizure Types
Most anticonvulsants can treat both focal seizures (which start in one area of the brain) and generalized seizures (which involve the whole brain at once). Valproic acid and levetiracetam are considered broad-spectrum, meaning they’re effective across multiple seizure types. Lamotrigine, oxcarbazepine, levetiracetam, topiramate, zonisamide, and lacosamide have all demonstrated effectiveness as first-line options for focal epilepsy.
A few drugs are more specialized. Ethosuximide is used almost exclusively for absence seizures, the brief “blank stare” episodes most common in children. Vigabatrin has a specific role in infantile spasms, particularly in children with tuberous sclerosis complex. For status epilepticus, a dangerous state of prolonged seizure activity, phenytoin remains a standard treatment.
Mood Stabilization in Bipolar Disorder
Several anticonvulsants double as mood stabilizers. Valproic acid is FDA-approved for acute mania and is considered a first-choice treatment in many guidelines, especially for atypical presentations. In clinical trials, about 48% of patients on valproic acid experienced at least a 50% reduction in manic symptoms after 21 days, compared to 25% on placebo. Valproic acid appears to work across a broader range of bipolar subtypes than lithium, with particular strength in mixed episodes (where manic and depressive symptoms overlap), rapid-cycling bipolar disorder, and cases complicated by substance abuse or anxiety disorders.
Carbamazepine has shown efficacy at least equal to lithium for classic mania in most comparative studies and may cover a wider range of bipolar subtypes, including mixed states and rapid-cycling patterns. Lamotrigine fills a different niche: it’s one of the few mood stabilizers with meaningful benefit for bipolar depression, where most other options show only modest effects.
Nerve Pain Treatment
Anticonvulsants are a cornerstone of treatment for neuropathic pain, the burning, shooting, or electric-shock sensations caused by damaged or misfiring nerves. The logic is straightforward: the same overexcitable nerve signaling that drives seizures also drives certain pain conditions.
Trigeminal neuralgia, a condition causing sudden, severe facial pain, illustrates this well. Sodium channel blockers like carbamazepine and oxcarbazepine are the most widely prescribed options. Carbamazepine is highly effective but limited by side effects affecting the nervous system and blood cell counts. Oxcarbazepine achieves similar pain control with better tolerability, though it can lower sodium levels in the blood. Lamotrigine offers comparable pain relief with fewer of these issues, making it a useful alternative for people who can’t tolerate the first-line options. Eslicarbazepine has shown promise even in cases related to multiple sclerosis.
For other types of nerve pain, gabapentin and pregabalin are among the most commonly prescribed anticonvulsants. Both work by binding to calcium channels on nerve cells, reducing the release of pain-signaling chemicals. They’re frequently used for diabetic neuropathy, postherpetic neuralgia (pain after shingles), and fibromyalgia.
Common Side Effects
Most anticonvulsants share a core set of side effects that reflect their brain-calming activity: tiredness, dizziness, stomach upset, and blurred vision. These tend to be worst during the first few weeks and often improve as the body adjusts. In children, drowsiness, inattention, and restlessness can affect learning and classroom performance.
Allergic skin reactions are a known risk across many anticonvulsants, ranging from mild rashes to rare but serious conditions like Stevens-Johnson syndrome, where the skin blisters and peels. Any new rash that develops after starting an anticonvulsant warrants prompt medical attention. There is also concern about increased suicidal thoughts in some older children and adolescents taking these medications, which is why mood changes are monitored during treatment.
Drug Interactions Worth Knowing
Some of the most important anticonvulsant interactions involve hormonal birth control. Carbamazepine, phenytoin, phenobarbital, primidone, oxcarbazepine, topiramate (at higher doses), and lamotrigine can all speed up the breakdown of estrogen and progestogen, potentially making the pill less effective. Carbamazepine at a standard dose can cut estrogen levels by roughly 50%. If you take one of these medications, a non-oral contraceptive method or a higher-dose formulation may be necessary.
The interaction with lamotrigine runs in both directions. While lamotrigine causes only a modest 19% reduction in progestogen levels, taking the combined contraceptive pill cuts lamotrigine levels by about 50%, which can lead to breakthrough seizures. Stopping the pill then causes lamotrigine levels to rebound, sometimes high enough to cause side effects.
By contrast, gabapentin, levetiracetam, pregabalin, valproic acid, vigabatrin, and zonisamide do not interact with oral contraceptives and cause few drug interactions overall. This is a meaningful advantage for people taking multiple medications.
The older enzyme-inducing drugs (carbamazepine, phenytoin, phenobarbital, primidone) can also dramatically reduce levels of blood thinners, immunosuppressants, cardiovascular medications, and psychiatric drugs. Valproic acid works differently: rather than speeding up the metabolism of other drugs, it slows down the breakdown of certain ones, notably phenobarbital and lamotrigine, which can raise their levels to a point where side effects appear.
Stopping an Anticonvulsant Safely
Anticonvulsants should never be stopped abruptly. Sudden withdrawal, especially of drugs that enhance GABA, can trigger rebound seizures or even status epilepticus, a medical emergency. Tapering is done gradually, with the dose reduced by a small fixed amount every two months or so. The total tapering process typically takes around seven months, though it can range from six weeks to nearly two years depending on the drug, the dose, and individual risk factors.
The decision to taper is increasingly treated as a shared one between patient and doctor, weighing the likelihood of staying seizure-free against the benefits of being medication-free. People with higher levels of certain inflammatory markers or those whose blood drug levels have already dipped below therapeutic range at the start of tapering appear to face a greater risk of seizure recurrence during the process.